Testing effectiveness (Phase 2)Not Yet RecruitingNCT07715734
What this trial is testing
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
Who this might be right for
Kidney Transplant RecipientCutaneous Squamous Cell Carcinoma (CSCC)Advanced Cutaneous Squamous Cell Carcinoma+1 more
Washington University School of Medicine 22